Literature DB >> 3047441

The clinical course of carotid bifurcation stenosis as determined by duplex scanning.

L M Taylor1, L Loboa, J M Porter.   

Abstract

Two hundred three patients had at least two carotid artery duplex (DS) examinations separated by at least 6 months (mean follow-up 18 months) and their risk factors, clinical outcome, and degree of carotid artery stenosis were compared. The accuracy of DS was established at greater than 90% by blinded comparison with angiography. During the study period 138 patients (68%) had stable carotid artery stenosis and 65 patients (32%) had progression of stenosis in at least one artery. Thirty patients had new symptoms of cerebrovascular disease (19 with transient ischemic attacks and 11 with stroke) during the study. It was not possible to predict which patients would become symptomatic on the basis of risk factor analysis or analysis of severity of stable carotid stenosis. Patients with progression of carotid artery stenosis to greater than 50% diameter reduction were significantly more likely (p less than 0.0001) to have new transient ischemic attack and stroke than were those with stable carotid artery stenosis, regardless of severity.

Entities:  

Mesh:

Year:  1988        PMID: 3047441     DOI: 10.1067/mva.1988.avs0080255

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  3 in total

1.  Noninvasive vascular diagnosis.

Authors:  L M Taylor
Journal:  West J Med       Date:  1989-08

2.  Antiphospholipid antibodies in vascular surgery patients. A cross-sectional study.

Authors:  L M Taylor; R W Chitwood; R L Dalman; G Sexton; S H Goodnight; J M Porter
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

3.  Prevalence of extracranial carotid atherosclerosis in the patients with coronary artery disease in a tertiary hospital in Malaysia.

Authors:  Mahavishnu Sahadevan; Kok Han Chee; Mei-Ling Sharon Tai
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.